Search Results

Cefixime: Uses, Dose, Side Effects and Top Brands in India (2026) - Vibcare Pharma

Cefixime: Uses, Dose, Side Effects and Top Brands in India (2026)

Vibcare Pharma

09/10/26

  • Updated 9 October 2026
  • Reviewed by Sudhanshu Singhal
  • 20 min read
  • 26 sources
32Vibcare cefixime products, all listed below
9compositions and strengths in the Vibcare range
BrandCompanyCommon pack and MRP (Rs) – Tata 1mg, read 9 Oct 2026
Taxim-O 200 TabletAlkem Laboratories LtdStrip of 10, ₹105.1
Zifi 200 TabletFDC LimitedStrip of 10, ₹105.11
Cefolac 200 TabletMacleods Pharmaceuticals Pvt LtdStrip of 10, ₹105.09
cEFix 200 TabletCipla LtdStrip of 10, ₹104.46
Omnix 200 DT Tablet (dispersible)Cipla LtdStrip of 10, ₹104.47
Ceftas 200 TabletIntas Pharmaceuticals LtdStrip of 10, ₹99.93
Mahacef 200 TabletMankind Pharma LtdStrip of 10, ₹99.76
Milixim 200 TabletGlenmark Pharmaceuticals LtdStrip of 10
Zifi 100 Dry SyrupFDC Limited30 mL bottle, ₹77.05
Taxim-O Forte Dry SyrupAlkem Laboratories Ltd30 mL bottle, ₹77.02
Cefolac 100 Oral SuspensionMacleods30 mL bottle, ₹77
Omnix 100 Dry SyrupCipla Ltd30 mL bottle, ₹76.54
Mahacef 100 Dry SyrupMankind Pharma Ltd30 mL bottle, ₹74.95
Taxim OF Tablet (cefixime 200 mg + ofloxacin 200 mg)Alkem Laboratories LtdStrip of 10, ₹217.55
Zifi O 200mg/200mg TabletFDC LtdStrip of 10, ₹208.3
Cefolac-O 200 Tablet (cefixime 200 mg + ofloxacin 200 mg)MacleodsStrip of 10, ₹217.7
Ceftas O Tablet (cefixime 200 mg + ofloxacin 200 mg)Intas Pharmaceuticals LtdStrip of 10, ₹216.56
Omnix O Tablet (cefixime 200 mg + ofloxacin 200 mg)Cipla LtdStrip of 10, ₹219.2
Mahacef-Plus Tablet (cefixime 200 mg + ofloxacin 200 mg)Mankind Pharma LtdStrip of 10, ₹173.42
Taxim-O CV 200 Tablet (cefixime 200 mg + clavulanic acid 125 mg)AlkemStrip of 10, ₹278.4
Zifi CV 200 Tablet (cefixime 200 mg + clavulanic acid 125 mg)FDC LtdStrip of 10, ₹364.34
Omnix CV Tablet (cefixime 200 mg + clavulanic acid 125 mg)CiplaStrip of 10, ₹347.9
Ceftas CV 200 mg/125 mg TabletIntasStrip of 10, ₹358.13
Mahacef-CV 200 Tablet (cefixime 200 mg + clavulanic acid 125 mg)MankindStrip of 6, ₹185.55
Cefolac CV 200 Tablet (cefixime 200 mg + clavulanic acid 125 mg)MacleodsStrip of 4, ₹153.1
Ziprax LB Tablet DT (cefixime 200 mg + lactic acid bacillus 60 million spores)Cipla LtdStrip of 10, ₹91.45
Cefitaxe 200 DT Tablet (cefixime 200 mg + lactic acid bacillus 60 million spores)Leeford Healthcare LtdStrip of 10, ₹104
MRPs as listed on the Indian e-pharmacy pages named under Sources, read 9 October 2026; prices change, so check the pack. Listed in no particular order unless the text says otherwise.

Every MRP above is the printed MRP shown on the Tata 1mg product page read on 9 October 2026, inclusive of taxes, except Milixim 200, whose product page showed no MRP line. MRPs vary by batch and change over time, so please check the current price at a pharmacy.

What is cefixime (alone and with ofloxacin, lactic acid bacillus or clavulanic acid)?

Cefixime is an oral third-generation cephalosporin antibiotic, a class of medicine within the wider beta-lactam family that also includes penicillins. The UK summary of product characteristics describes it under ATC code J01DD08, and the US label calls it a semisynthetic cephalosporin antibacterial for oral administration.

How it works

Cefixime kills bacteria rather than simply slowing them down. The US label states that the bactericidal action of cefixime results from inhibition of cell wall synthesis, so in plain words the bacteria cannot hold together.

It is described as stable in the presence of certain beta-lactamase enzymes, the enzymes some bacteria use to resist penicillins, so some of those bacteria may still be susceptible to cefixime. The same label lists organisms that are resistant to it, including Pseudomonas, Enterococcus, most staphylococci and most Enterobacter, and notes limited activity against bacteria producing extended-spectrum beta-lactamases.

Forms and strengths sold in India

NLEM 2022 lists cefixime as tablet 200 mg, tablet 400 mg, oral liquid 50 mg/5 mL and oral liquid 100 mg/5 mL. Indian pharmacy catalogues additionally list 100 mg tablets, dispersible tablets of 50 mg, 100 mg and 200 mg, dry syrups of 50 mg, 100 mg and 200 mg per 5 mL in 30 mL and 60 mL bottles, and paediatric drops.

Around 40% to 50% of an oral dose of cefixime is absorbed, and the serum half-life in healthy subjects averages 3 to 4 hours. The WHO Model List of Essential Medicines lists cefixime as powder for oral liquid 100 mg/5 mL and as solid oral dosage forms of 200 mg and 400 mg.

What each combination partner adds

  • Ofloxacin is a fluoroquinolone antibiotic that works in a different way, by inhibiting bacterial topoisomerase IV and DNA gyrase, the enzymes bacteria need to copy and repair their DNA.
  • Lactic acid bacillus is a probiotic, that is, live spore bacteria added to try to reduce antibiotic-associated diarrhoea. It is not an antibiotic. The CDSCO approved-combination list words this combination as being for adults prone to antibiotic associated diarrhoea, and records it with 2.5 billion spores, while several marketed brands are listed with 60 million spores; this difference could not be verified.
  • Clavulanic acid is a beta-lactamase inhibitor. The US amoxicillin-clavulanate label explains that clavulanic acid blocks the active sites of a wide range of beta-lactamase enzymes and restores activity against certain beta-lactamase-producing bacteria. That label is for amoxicillin; no separate cefixime-clavulanic acid product label was found in the US or UK sources used.

What is it used for?

Cefixime is used only for infections proven or strongly suspected to be caused by susceptible bacteria, and the approved uses differ slightly between the US, the UK and Indian sources.

Uses stated in the US and UK labels

The US label for cefixime oral suspension and 400 mg capsule lists uncomplicated urinary tract infections caused by susceptible Escherichia coli and Proteus mirabilis; otitis media caused by susceptible Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes; pharyngitis and tonsillitis caused by susceptible Streptococcus pyogenes; acute exacerbations of chronic bronchitis caused by susceptible Streptococcus pneumoniae and Haemophilus influenzae; and uncomplicated cervical or urethral gonorrhoea caused by susceptible Neisseria gonorrhoeae. The US 400 mg tablet label limits the urinary tract, bronchitis and gonorrhoea uses to patients weighing more than 45 kg or older than 12 years.

The UK summary of product characteristics lists acute infections caused by susceptible organisms: upper respiratory tract infections such as otitis media where the organism is known or suspected to be resistant to other commonly used antibiotics or where treatment failure carries significant risk, lower respiratory tract infection such as bronchitis, and urinary tract infections such as cystitis, cystourethritis and uncomplicated pyelonephritis.

Uses in Indian guidance and approved combination indications

The ICMR 2019 treatment guidelines list cefixime as an alternative, not a first choice, for typhoid fever, and name cefixime in a few specific situations, such as in children with non-anaphylactic penicillin allergy in bacterial sinusitis, and within a regimen for mild-to-moderate pelvic inflammatory disease. Typhoid fever is not an indication in the US label, and a 2022 Cochrane review concluded that cefixime can be used for enteric fever but may not perform as well as fluoroquinolones, while a 2026 trial of 1,847 patients found no benefit from adding cefixime to azithromycin.

CDSCO's approved-combination records give the indication for cefixime with ofloxacin as "typhoid fever and urinary tract infection in adults", and for cefixime with lactic acid bacillus as "urinary tract infections, respiratory tract infections, biliary tract infections in adult patients prone to antibiotic associated diarrhoea". For cefixime with clavulanic acid the CDSCO list shows only the word "Antibiotic" in the indication column.

What it does not treat

Cefixime does not treat viral infections such as the common cold. The US label states that antibacterial drugs, including cefixime, should only be used to treat bacterial infections, and the ICMR guidelines state that antimicrobial therapy is not indicated for viral upper respiratory infections and that antibiotics are not indicated for acute bronchitis.

Dose as stated in the labels

The doses below are the doses written in the official labels and guidelines, not advice for any individual; always take cefixime in the exact dose and for the exact duration your doctor prescribes.

Adults

The usual adult dose stated in the US label is 400 mg daily, either as one 400 mg tablet daily or as half a 400 mg tablet every 12 hours. For uncomplicated cervical or urethral gonorrhoea the label states a single oral dose of 400 mg, and in Streptococcus pyogenes infections treatment is stated as at least 10 days.

The UK summary of product characteristics states 200 to 400 mg daily for adults and children over 10 years or weighing more than 50 kg, given either as a single dose or in two divided doses according to the severity of infection, with a usual course of 7 days, which may be continued for up to 14 days if required.

Children

The US label, for children 6 months and older on the oral suspension, states 8 mg/kg/day given as one daily dose or in two divided doses of 4 mg/kg every 12 hours, and its weight chart runs from 50 mg daily for a 5 to 7.5 kg child up to 400 mg daily for 45.1 kg or more. Children weighing more than 45 kg or older than 12 years are treated with the recommended adult dose, and safety under 6 months of age is not established. For otitis media the label states the suspension should be used and that the tablet or capsule should not be substituted for it.

The ICMR 2019 standard-dose table lists cefixime as 20 mg/kg/day, and for typhoid gives a duration of 10 to 14 days. The UK 200 mg tablet is not recommended for children under 10 years.

Timing, food and kidney impairment

Both the US and UK labels state that cefixime can be taken without regard to food or meals; the US label notes that food delays the time to peak and lowers absorption of the 400 mg capsule to some extent. In kidney impairment the dose may need to change, and the labels differ by country and by form: the US label keeps the normal dose only if creatinine clearance is 60 mL/min or more, says the 400 mg tablet is not appropriate between 21 and 59 mL/min or on haemodialysis, and gives separate reduced doses for the suspension, while the UK label keeps the normal dose down to 20 mL/min and caps it at 200 mg once daily below that. The doctor sets the dose from kidney function; do not change it yourself.

A reconstituted bottle of the US-label suspension may be kept for 14 days at room temperature or in a refrigerator, shaken well before each use, and any leftover portion discarded after 14 days. For the cefixime combinations with ofloxacin, lactic acid bacillus or clavulanic acid, no official combination dose was found in the CDSCO, US or UK sources used, so the dose must be taken only as prescribed by the doctor from the product's own verified prescribing information.

Side effects

The most common side effects of cefixime are stomach and bowel related, and most reactions are described as mild and self-limiting.

Common side effects

In US trials of the tablet, gastrointestinal events were reported in 30% of adult patients, and 5% of patients stopped treatment because of drug-related adverse reactions. The individual rates listed are diarrhoea 16%, nausea 7%, loose or frequent stools 6%, flatulence 4%, abdominal pain 3% and dyspepsia 3%, with vomiting also listed; in children on the suspension, gastrointestinal effects were comparable to those in adults.

The UK summary adds headache, dizziness, rash, itching and urticaria without giving frequencies, and notes that diarrhoea has been more commonly associated with higher doses and that treatment should be stopped if marked diarrhoea occurs.

Serious side effects that need urgent medical help

  • Hypersensitivity reactions including anaphylaxis with shock, angioedema, facial oedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis and serum-sickness-like reactions.
  • Clostridioides difficile-associated diarrhoea, which the US label says may range from mild diarrhoea to fatal colitis and has been reported to occur more than two months after the administration of antibacterial agents; watery or bloody stools, with or without cramps and fever, need a doctor's opinion even more than two months after the last dose.
  • Liver, kidney and blood effects: raised liver enzymes, hepatitis, jaundice, raised blood urea and creatinine, acute renal failure, thrombocytopenia, leukopenia, neutropenia, pancytopenia and agranulocytosis.
  • The UK label also warns about encephalopathy with convulsions or confusion, especially in the elderly or in severe renal impairment, severe skin reactions, haemolytic anaemia and acute renal failure with tubulointerstitial nephritis.

Wherever cefixime is combined with ofloxacin, in tablets or in dry syrups, the ofloxacin label carries a boxed warning about disabling and potentially irreversible reactions that can occur together, such as tendinitis and tendon rupture, peripheral neuropathy and central nervous system effects; the label says to stop the medicine at once if any of these occur. The same warning says ofloxacin may worsen muscle weakness in myasthenia gravis and should be avoided in people with a known history of it. The tendon risk is higher above 60 years of age, with corticosteroids, and after kidney, heart or lung transplant, and tendon rupture can occur up to several months after the course ends.

Who should not take it, and interactions

Cefixime must not be taken by anyone with a known allergy to cefixime or to other cephalosporins, and it must be used with caution in people with a history of penicillin allergy. Cefixime + ofloxacin products must also not be taken by anyone with a history of allergy to ofloxacin or any other quinolone antibiotic.

  • Allergy: the US label says cross-hypersensitivity among beta-lactams may occur in up to 10% of patients with a history of penicillin allergy; the UK label says to use it with caution in penicillin hypersensitivity because some patients have had severe reactions to both classes.
  • Kidney impairment: the US label requires dose adjustment below a creatinine clearance of 60 mL/min.
  • Carbamazepine: elevated carbamazepine levels have been reported.
  • Theophylline (ofloxacin combinations): ofloxacin can raise theophylline levels, with a risk of seizures, and it may also strengthen the effect of warfarin.
  • This list is not complete: read the product leaflet and tell your doctor or pharmacist about every medicine you take.
  • Warfarin and other anticoagulants: increased prothrombin time, with or without bleeding, has been reported, and the UK label advises caution with coumarin-type anticoagulants.
  • Lab tests: false-positive urine glucose with Benedict's or Fehling's solutions, false-positive urine ketones with nitroprusside tests and a false-positive direct Coombs test.

Pregnancy and breastfeeding

The US label states that published data over several decades have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes, while the UK summary states that Suprax should not be used in pregnancy or in nursing mothers unless considered essential by the physician. For breastfeeding, the US label reports no data on the presence of cefixime in human milk and advises weighing the benefits of breastfeeding against the mother's need for the medicine.

For the ofloxacin-containing combination, the ofloxacin label states that safety and efficacy in patients under 18 years, pregnant women and lactating women have not been established. The label also advises not to take antacids containing calcium, magnesium or aluminium, sucralfate, iron, zinc-containing supplements or mineral supplements within two hours before or two hours after ofloxacin, because they reduce its absorption.

Rules in India

Cefixime is a Schedule H1 antibiotic in India, which means it can be sold only against the prescription of a Registered Medical Practitioner and every sale is recorded.

Schedule H1, the red Rx symbol and the Red Line campaign

Cefixime is named in Schedule H1 of the Drugs and Cosmetics Rules, 1945, and the rules require the formulation to carry a red "Rx" symbol at the top left and a box with a red border reading "SCHEDULE H1 DRUG - WARNING. It is dangerous to take this preparation except in accordance with the medical advice. Not to be sold by retail without the prescription of a Registered Medical Practitioner." Supply of a Schedule H1 drug is entered in a separate register, with records kept for three years and open to inspection.

The Ministry of Health's Red Line awareness campaign on antimicrobial resistance urges people not to use medicines marked with a red vertical line without a doctor's prescription, and antibiotics are included among the medicines covered by the campaign.

NLEM 2022 and the NPPA ceiling price

NLEM 2022 lists cefixime at item 6.2.1.8 under beta-lactam medicines, with tablet 200 mg, tablet 400 mg and oral liquids of 50 mg/5 mL and 100 mg/5 mL. The list does not include cefixime combined with ofloxacin, lactic acid bacillus or clavulanic acid, and clavulanic acid appears there only with amoxicillin.

One price is quoted here because it is dated and sourced: the ceiling price of cefixime capsule 400 mg is ₹37.28 per capsule with effect from 1 April 2026, as part of the annual wholesale price index revision; the source is a news reproduction of the NPPA notification table rather than the NPPA document itself. Because the combinations are not in NLEM 2022, no NLEM-based ceiling price for them was found.

WHO AWaRe group and the WHO list

The WHO AWaRe classification places cefixime in the WATCH group of third-generation cephalosporins, a group the WHO says has higher resistance potential and should be a key target of stewardship programmes and monitoring. On the WHO Model List of Essential Medicines 2025, cefixime has no first-choice indication and second-choice indications for acute invasive bacterial diarrhoea or dysentery and for gonorrhoea.

Widely available brands in India

Cefixime is sold in India by many companies in tablets, dispersible tablets, dry syrups and the common combinations with ofloxacin, clavulanic acid and lactic acid bacillus; the table at the top of this page lists widely available brands, their companies, packs and the MRP printed on Tata 1mg on 9 October 2026. No published sales ranking from a named data source was found, so this is a list of widely available brands and not a ranking of bestsellers.

The Vibcare range

Vibcare's cefixime range covers 32 products in 9 compositions: single-ingredient tablets and dispersible tablets of 100 mg and 200 mg, dry syrups of 50 mg and 100 mg, and fixed combinations with ofloxacin, with lactic acid bacillus 60 million spores and with clavulanic acid 125 mg, in packs from 30 mL bottles to 10x10 alu-alu packs.

Cefixime 100 mg

4 divisions

Cefixime 200 mg

4 divisions

Cefixime 200 mg + Clavulanic Acid 125 mg

2 divisions

Cefixime 200 mg + Lactic Acid Bacillus 60Million Spores

4 divisions

Cefixime 200 mg + Ofloxacin 200 mg

4 divisions

Cefixime 50 (Wfi)Mg.

Prima

Cefixime 50 mg

2 divisions

Cefixime 50 mg + Lactic Acid Bacillus 60Million Spores

Prima

Cefixime 50 mg + Ofloxacin 50 mg

3 divisions

For distributors and entrepreneurs

Add cefixime to your range

Vibcare appoints one PCD franchise partner per district, with monopoly rights confirmed in writing. Trade rates for every product are on its product page.

Frequently asked questions

Is cefixime used for typhoid?

In India, the ICMR 2019 guidelines list cefixime as an alternative drug for typhoid fever, to be given for 10 to 14 days and changed as per susceptibility testing, while CDSCO has approved a cefixime and ofloxacin combination for typhoid fever and urinary tract infection in adults. Typhoid fever is not an indication in the US label, a 2022 Cochrane review says cefixime may not perform as well as fluoroquinolones for enteric fever, and a 2026 trial found no benefit from adding cefixime to azithromycin.

Can cefixime be taken with milk or food?

Both the US and the UK labels state that cefixime can be taken without regard to food or meals, and the UK label says absorption is not significantly modified by food. Neither label mentions milk specifically, so for a milk-related doubt please ask your doctor or pharmacist.

Is cefixime safe for children?

The US label supports use of the oral suspension from 6 months of age at the dose stated in the label, and says safety and effectiveness under 6 months of age are not established; the UK 200 mg tablet is not recommended for children under 10 years. Children must be given cefixime only in the dose a doctor prescribes, and for otitis media the label states the suspension should be used instead of the tablet or capsule.

Does cefixime work for cold, cough or flu?

No. Cefixime is an antibacterial medicine and does not treat viral infections such as the common cold; the US label states that antibacterial drugs, including cefixime, should only be used to treat bacterial infections. The ICMR guidelines state that antimicrobial therapy is not indicated for viral upper respiratory infections and that antibiotics are not indicated for acute bronchitis.

Can I stop when I feel better?

The US label says that it is common to feel better early in the course, but the medicine should be taken exactly as directed by the doctor, because skipping doses or not finishing the course may reduce effectiveness and increase resistance. Do not stop or change the course on your own; speak to your prescribing doctor.

Is cefixime safe in pregnancy and breastfeeding?

The US label states that published human data have not established drug-associated risks of major birth defects, miscarriage or adverse maternal and fetal outcomes, while the UK summary says cefixime should not be used in pregnancy or by nursing mothers unless the physician considers it essential. There are no human milk data in the US label, so any decision in pregnancy or breastfeeding must be taken by the treating doctor.

Why do I get loose motions on cefixime?

Diarrhoea was the most common side effect in the US trials at 16%, with loose or frequent stools at 6%, and the UK label says diarrhoea is more common at higher doses. Watery or bloody stools, with or without cramps and fever, need to be reported to a doctor even more than two months after the last dose, because Clostridioides difficile-associated diarrhoea has been reported to occur over two months after antibacterial treatment.

Do probiotics (lactic acid bacillus) prevent antibiotic diarrhoea?

A Cochrane review in children found diarrhoea in 8% of those given probiotics compared with 19% of controls, described as moderate-certainty evidence, though the review covered mixed probiotic strains and not this specific combination. A 2025 Cochrane update in adults and children found that probiotics may reduce Clostridioides difficile-associated diarrhoea on low-certainty evidence.

Why can I only buy cefixime on prescription in India?

Cefixime is named in Schedule H1 of the Drugs and Cosmetics Rules, 1945, and the rules state that it is dangerous to take the preparation except in accordance with medical advice and that it is not to be sold by retail without the prescription of a Registered Medical Practitioner. Each supply of a Schedule H1 drug is recorded in a separate register, with records kept for three years and open to inspection.

Sources

Show all 26 sources
  1. eMC (ADVANZ Pharma) – Suprax 200 mg film-coated tablets: summary of product characteristics
  2. DailyMed (US FDA) – cefixime for oral suspension and 400 mg capsule (Lupin): drug label
  3. DailyMed (US FDA) – cefixime 400 mg tablets (Rising): drug label
  4. DailyMed (US FDA) – ofloxacin tablets: drug label
  5. DailyMed (US FDA) – amoxicillin and clavulanate potassium: drug label
  6. ICMR – Treatment Guidelines for Antimicrobial Use in Common Syndromes, 2nd edition 2019
  7. CDSCO – Fixed dose combinations approved by DCG(I) since 1961 to 31st December 2019
  8. CDSCO – Approved drugs from 01.01.2010 to 31.12.2010 (cefixime and ofloxacin combination entry)
  9. CDSCO – New drug approvals list (cefixime and ofloxacin dispersible tablet)
  10. CDSCO – Drugs and Cosmetics Rules, 1945 (Schedule H1 and Rule 97 labelling)
  11. Ministry of Health and Family Welfare, hosted by CDSCO – National List of Essential Medicines 2022
  12. WHO – Model List of Essential Medicines, 24th list, 2025
  13. WHO – Model List of Essential Medicines 2025, full list document
  14. WHO – AWaRe classification of antibiotics, 2023
  15. WHO – AWaRe classification of antibiotics, 2025
  16. Toxics Link – Parliament Q&A (Rajya Sabha Unstarred Q.266, answered 4 February 2025) on antimicrobial drug labelling and the Red Line campaign
  17. PubMed – Cochrane review: probiotics for prevention of antibiotic-associated diarrhoea in children (33 studies, 6,352 participants)
  18. PubMed – Cochrane 2025 update: probiotics and Clostridioides difficile-associated diarrhoea (47 studies)
  19. PubMed – Cochrane 2022 review on drug treatment of enteric fever (27 randomised trials, 2,231 participants)
  20. PubMed – Lancet Infectious Diseases trial, August 2026: cefixime added to azithromycin in enteric fever (1,847 patients)
  21. Medical Dialogues – NPPA revision of ceiling prices with WPI-linked hike effective 1 April 2026 (news reproduction of the notification table)
  22. Tata 1mg – cefixime 200 mg tablet brand pages, read 9 October 2026: Taxim-O 200, Zifi 200, Cefolac 200, cEFix 200, Omnix 200 DT, Ceftas 200, Mahacef 200, Milixim 200
  23. Tata 1mg – cefixime dry syrup brand pages, read 9 October 2026: Zifi 100 Dry Syrup, Taxim-O Forte Dry Syrup, Cefolac 100 Oral Suspension, Omnix 100 Dry Syrup, Mahacef 100 Dry Syrup
  24. Tata 1mg – cefixime and ofloxacin brand pages, read 9 October 2026: Taxim OF, Zifi O 200mg/200mg, Cefolac-O 200, Ceftas O, Omnix O, Mahacef-Plus
  25. Tata 1mg – cefixime and clavulanic acid brand pages, read 9 October 2026: Taxim-O CV 200, Zifi CV 200, Omnix CV, Ceftas CV 200 mg/125 mg, Mahacef-CV 200, Cefolac CV 200
  26. Tata 1mg – cefixime and lactic acid bacillus brand pages, read 9 October 2026: Ziprax LB Tablet DT, Cefitaxe 200 DT Tablet
For distributors and entrepreneurs

Add cefixime to your range

Vibcare appoints one PCD franchise partner per district, with monopoly rights confirmed in writing. Trade rates for every product are on its product page.

About this article. Written by the Vibcare Pharma team from the sources listed above and reviewed by Sudhanshu Singhal, Director & Co-Founder, Vibcare Pharma. Figures are as published on the dates shown. Medical information here is general information, not a substitute for advice from a doctor.

Copy Link

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Business Enquiry

Request a callback to get more information about becoming a Partner